DNAJC19P3

Across TCGA pan-cancer cohorts, DNAJC19P3 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated DNAJC19P3 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher DNAJC19P3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DNAJC19P3 expression acts as an unfavorable survival marker, although some lineages such as ESCA and HNSC show a favorable association.

THCA, SKCM, and BLCA are the cancer types where DNAJC19P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	IV	0.027	0.937	<.001	72	view →
SKCM	OS	Tertile	All	0.145	0.781	<.001	42	view →
BLCA	DFS	Tertile	III,IV	0.176	0.338	.013	18	view →
THYM	DFS	Tertile	All	0.134	0.871	<.001	18	view →
ESCA	OS	Tertile	III,IV	0.754	0.327	.006	18	view →
LUAD	OS	Tertile	II,III,IV	0.245	0.591	.036	9	view →
HNSC	OS	Tertile	All	0.854	0.675	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

DNAJC19P3–THCA (DFS)

Open the THCA breakdown →